When can a risk factor be used as a worthwhile screening test?

BMJ (Clinical research ed.) ·Vol. 319 ·No. 7224 ·1999-12-11 ·Pages 1562-5

Wald NJ, Hackshaw AK, Frost CD

Abstract

暂无摘要

MeSH Terms

False Positive Reactions Humans Mass Screening/methods Odds Ratio Risk Assessment Risk Factors Sensitivity and Specificity

Authors & Affiliations

3 authors, click to expand affiliations / ORCID

Wald N J

Department of Environmental Medicine, Wolfson Institute of Preventive Medicine, St Bartholomew's Hospital, London EC1M 6BQ. n.j.wald@mds.qmw.ac.uk

Hackshaw A K

Frost C D

References (2)

2 references, click to expand

Apolipoproteins and ischaemic heart disease: implications for screening.
Lancet. 1994 Jan 8;343(8889):75-9 PMID: 7903777
Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight.
Br J Obstet Gynaecol. 1992 Feb;99(2):144-9 PMID: 1372820

Article Info

Journal

BMJ (Clinical research ed.)

Abbr.

BMJ

ISSN

0959-8138

DOI

Published

1999-12-11

Pages

1562-5

Language

English

Region

England

NLM ID

8900488

PMCID

PMC1117271

Subset

External Links

Analysis Services